2004 Meeting Home

      Scientific Program

      Hotel/Travel Info

      Photo Gallery

      Abstract Submission

      Sponsors & Exhibitors

      Past Meetings

      Accreditation

      Society Home

Jointly sponsored by the International Society for Magnetic Resonance in Medicine

To browse the online program planner for the Third Annual Meeting of the Society for Molecular Imaging, please click here.

To download a PDF file of the final program, please click here.

The field of in vivo cellular and molecular imaging is exploding with new approaches that reveal aspects of biology in the living body, far beyond that of cancer, that were until recently inaccessible to investigation. The rapidly evolving imaging technologies to be described at the Third Annual Meeting of the Society for Molecular Imaging are designed to reveal biological changes in vivo, and thus can be used to improve the study of biology and disease, accelerate the development of new therapeutic approaches and expand the use of these technologies to a wide range of disciplines.

The meeting environment will be one where we discuss imaging broadly, and will include talks and discussion in areas of biology, chemistry, clinical imaging, genomics, technical advancements and industrial applications. New insights into mammalian biology that have been realized through imaging will be a key focus of the meeting. The goal is by the end of the meeting for the participants to have gained a greater understanding of the current status of the field, to leave this meeting with new ideas and the potential for making broad collaborations outside of their specific areas and to appreciate the future of cellular and molecular studies in the living body.

On behalf of the Scientific Program Committee, we invite you to join us for this exciting event in in vivo discovery.

MEETING CHAIRMAN:

Dr. David Piwnica-Worms, Washington University in St. Louis

MEETING CO-CHAIRS:

Dr. Joseph J.H. Ackerman, Washington University in St. Louis
Dr. Michael J. Welch, Washington University in St. Louis

STEERING COMMITTEE:

Dr. James P. Basilion, MGH/Harvard Medical School
Dr. Ronald G. Blasberg, Memorial Sloan Kettering Cancer Ctr
Dr. June-Key Chung, Seoul National University Hospital
Dr. Christopher H. Contag, Stanford University School of Medicine
Dr. Scott E. Fraser, California Institute of Technology
Dr. Yasuhisha Fujibayashi, Fukui Medical University
Dr. Juri Gelovani, UT MD Anderson Cancer Center
Dr. Andreas H. Jacobs, University of Cologne
Dr. Thomas J. Meade, Northwestern University
Dr. Chrit Moonen, Universite Victor Segalen
Dr. Brian D. Ross, University of Michigan
Dr. Markus Schwaiger, Technical University of Munich
Dr. Eva M. Sevick-Muraca, Texas A&M University
Dr. Wynn A. Volkert, University of Missouri
Dr. Ralph Weissleder, MGH/Harvard Medical School

SCIENTIFIC PROGRAM COMMITTEE

Samuel Achilefu, PhD, Washington Univ. School of Medicine, USA
Joseph Ackerman, PhD, Washington University, USA
Silvio Aime, PhD, University of Torino, Italy
Carolyn Anderson, PhD, Washington University School of Medicine, USA
James Basilion, PhD, MGH/Harvard Medical School, USA
Frank Bengel, MD, Technische Universität München, Germany
Zaver Bhujwalla, PhD, Johns Hopkins University, USA
Ronald Blasberg, MD, Memorial Sloan-Kettering Cancer Center., USA
Alexei Bogdanov, PhD, Massachusetts General Hospital, USA
Thomas Budinger, PhD, Univ. of California Berkeley, USA
Simon Cherry, PhD, University of California, Davis, USA
June-Key Chung, MD, PhD, Seoul National University Hospital, Korea
Christopher Contag, PhD, Stanford University School of Medicine, USA
Susan Deutscher, PhD, University of Missouri, USA
William Eckelman, PhD, Institutes of Health, USA
Katherine Ferrara, PhD, University of California, USA
Joseph Frank, MD, National Institutes of Health, USA
Scott Fraser, PhD, California Institute of Technology, USA
Yasuhisa Fujibayashi, MD, PhD, Fukui Medical University, Japan
Sanjiv Gambhir, MD, PhD, Stanford University, USA
Juri Gelovani, MD, PhD, UT MD Anderson Cancer Center, USA
Robert Gillies, PhD, University of Arizona, USA
Jerry Glickson, PhD, Univ. of Penn. School of Medicine, USA
Jonathan Hardy, PhD, Stanford University, USA
Eric Holland, MD, PhD, Memorial Sloan-Kettering Cancer Center, USA
Andreas Jacobs, MD, Lab for Gene Therapy and Mol Imaging, Germany
Lynne Johnson, MD, Brown University, USA
Steven Larson, MD, Memorial Sloan-Kettering Cancer Center, USA
Thomas Meade, PhD, Northwestern University, USA
Chrit Moonen, PhD, Universite Victor Segalen Bordeaux 2, France
Michael Moseley, PhD, Stanford University, USA
Vasilis Ntziachristos, PhD, Massachucetts General Hospital, USA
David Piston, PhD, Vanderbilt University, USA
David Piwnica-Worms, MD, PhD, Washington Univ. School of Medicine, USA
Martin Pomper, MD, PhD, Johns Hopkins Univ. School of Medicine, USA
Lee Ratner, MD, PhD, Washington University School of Medicine, USA
Brian Ross, PhD, University of Michigan, USA
Jan Schnitzer, MD, Sidney Kimmel Cancer Center, USA
Eva Sevick-Muraca, PhD, Texas A&M University, USA
Vijay Sharma, PhD, Washington University Medical School, USA
Bruce Tromberg, PhD, University of California, Irvine, USA
George Van de Woude, PhD, Van Andel Research Institute, USA
Henry VanBrocklin, PhD, Lawrence Berkeley National Laboratory, USA
Wynn Volkert, PhD, University of Missouri, USA
Ralph Weissleder, MD, PhD, MGH/Harvard Medical School, USA
Michael Welch, PhD, Washington University School of Medicine, USA
Samuel Wickline, MD, Washington University School of Medicine, USA

The Society for Molecular Imaging
PO Box 293878
Kerrville, TX 78029-3878 USA
1-830-257-0112; Fax: 1-830-257-0119

Secretariat
Joan Oefner
email: joefner@molecularimaging.org

Director of Education
Charles Metzger
email: cmetzger@molecularimaging.org